Additional file 5: of MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design

Table S5. Amino acid sequences of predicted MHC class I binding neo-peptides in 147 lung adenocarcinoma patients in this study. (XLSX 534 kb)